Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-25 @ 9:54 PM
Study NCT ID:
NCT05300451
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-10-30
First Post:
2022-02-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Daratumumab in HLA Desensitization Prior to Transplantation
Sponsor:
Barry A. Boilson
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-08
First Submit QC Date:
None
Study First Post Date:
2022-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-29
Last Update Post Date:
2025-10-30
Last Update Post Date Type:
ESTIMATED